Terms: = Endocrine gland cancer AND B2M, P61769, 567, ENSG00000166710 AND Treatment
47 results:
1. Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database.
Dixit J; Gupta N; Kataki A; Roy P; Mehra N; Kumar L; Singh A; Malhotra P; Gupta D; Goyal A; Rajsekar K; Krishnamurthy MN; Gupta S; Prinja S
Health Qual Life Outcomes; 2024 Mar; 22(1):26. PubMed ID: 38481231
[TBL] [Abstract] [Full Text] [Related]
2. Significance of Continuous Low-Dose Lenvatinib for the Treating of the Patients with Unresectable Thyroid Carcinoma.
Murakami D; Nishimoto K; Takao S; Miyamaru S; Kadowaki T; Saito H; Takeda H; Ise M; Suyama K; Orita Y
Acta Med Okayama; 2024 Feb; 78(1):63-70. PubMed ID: 38419316
[TBL] [Abstract] [Full Text] [Related]
3. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
[TBL] [Abstract] [Full Text] [Related]
4. Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Koyama J; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2023 Nov; 30(11):1044-1050. PubMed ID: 37522577
[TBL] [Abstract] [Full Text] [Related]
5. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for treatment of Pancreatic Insulinoma.
Crinò SF; Napoleon B; Facciorusso A; Lakhtakia S; Borbath I; Caillol F; Do-Cong Pham K; Rizzatti G; Forti E; Palazzo L; Belle A; Vilmann P; van Laethem JL; Mohamadnejad M; Godat S; Hindryckx P; Benson A; Tacelli M; De Nucci G; Binda C; Kovacevic B; Jacob H; Partelli S; Falconi M; Salvia R; Landoni L; ; Larghi A
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2834-2843.e2. PubMed ID: 36871765
[TBL] [Abstract] [Full Text] [Related]
6. TGF-β2 antisense oligonucleotide enhances T-cell mediated anti-tumor activities by IL-2 via attenuation of fibrotic reaction in a humanized mouse model of pancreatic ductal adenocarcinoma.
Lee HK; Nam MW; Go RE; Koo J; Kim TH; Park JE; Choi KC
Biomed Pharmacother; 2023 Mar; 159():114212. PubMed ID: 36610224
[TBL] [Abstract] [Full Text] [Related]
7. Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study.
Li X; Ding Y; Liu Y; Yang M
J Ovarian Res; 2022 Dec; 15(1):125. PubMed ID: 36456989
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of homologous recombination deficiency from cancer gene expression data.
Kang J; Lee J; Lee A; Lee YS
J Int Med Res; 2022 Nov; 50(11):3000605221133655. PubMed ID: 36380518
[TBL] [Abstract] [Full Text] [Related]
9. Bariatric surgery reduces the risk of pancreatic cancer in individuals with obesity before the age of 50 years: A nationwide administrative data study in France.
Bulsei J; Chierici A; Alifano M; Castaldi A; Drai C; De Fatico S; Rosso E; Fontas E; Iannelli A
Eur J Surg Oncol; 2023 Apr; 49(4):788-793. PubMed ID: 36376141
[TBL] [Abstract] [Full Text] [Related]
10. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation.
Manuel-Vázquez A; Balakrishnan A; Agami P; Andersson B; Berrevoet F; Besselink MG; Boggi U; Caputo D; Carabias A; Carrion-Alvarez L; Franco CC; Coppola A; Dasari BVM; Diaz-Mercedes S; Feretis M; Fondevila C; Fusai GK; Garcea G; Gonzabay V; Bravo MÁG; Gorris M; Hendrikx B; Hidalgo-Salinas C; Kadam P; Karavias D; Kauffmann E; Kourdouli A; La Vaccara V; van Laarhoven S; Leighton J; Liem MSL; Machairas N; Magouliotis D; Mahmoud A; Marino MV; Massani M; Requena PM; Mentor K; Napoli N; Nijhuis JHT; Nikov A; Nistri C; Nunes V; Ruiz EO; Pandanaboyana S; Saborido BP; Pohnán R; Popa M; Pérez BS; Bueno FS; Serrablo A; Serradilla-Martín M; Skipworth JRA; Soreide K; Symeonidis D; Zacharoulis D; Zelga P; Aliseda D; Santiago MJC; Mancilla CF; Fragua RL; Hughes DL; Llorente CP; Lesurtel M; Gallagher T; Ramia JM;
Langenbecks Arch Surg; 2022 Dec; 407(8):3447-3455. PubMed ID: 36198881
[TBL] [Abstract] [Full Text] [Related]
11. endocrine surgeons are performing more thyroid lobectomies for low-risk differentiated thyroid cancer since the 2015 ATA guidelines.
Conroy PC; Wilhelm A; Calthorpe L; Ullmann TM; Davis S; Huang CY; Shen WT; Gosnell J; Duh QY; Roman S; Sosa JA
Surgery; 2022 Nov; 172(5):1392-1400. PubMed ID: 36002375
[TBL] [Abstract] [Full Text] [Related]
12. [Minimally invasive enucleation for benign and low-grade malignant pancreatic tumors: an analysis of 60 cases].
Liu MQ; Liu WS; Li Z; Zhuo QF; Ji SR; Xu WY; Shi YH; Yu XJ; Xu XW
Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):674-679. PubMed ID: 35775260
[No Abstract] [Full Text] [Related]
13. Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.
Sutton W; Crepeau PK; Canner JK; Karzai S; Segev DL; Mathur A
Am J Surg; 2022 Jul; 224(1 Pt B):412-417. PubMed ID: 35123768
[TBL] [Abstract] [Full Text] [Related]
14. [Comparative clinical efficacy analysis of pancreatoduodenectomy for distal bile duct and pancreatic head cancer: a report of 1 005 cases].
Wu PF; Zhang K; Lu ZP; Lin JZ; Chen JM; Xi CH; Wei JS; Guo F; Tu M; Jiang KR; Miao Y
Zhonghua Wai Ke Za Zhi; 2022 Feb; 60(2):128-133. PubMed ID: 35012271
[No Abstract] [Full Text] [Related]
15. Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic cancer Action Network (PanCAN) online patient registry experience.
Gupta A; Khalid O; Moravek C; Lamkin A; Matrisian LM; Doss S; Denlinger CS; Coveler AL; Weekes CD; Roeland EJ; Hendifar AE; Nipp RD
Cancer Med; 2021 Oct; 10(20):7152-7161. PubMed ID: 34477302
[TBL] [Abstract] [Full Text] [Related]
16. Fertility and reproductive technology use in testicular cancer survivors in Japan: A multi-institutional, cross-sectional study.
Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Yamada S; Nishimura K; Nonomura N; Kojo K; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2021 Oct; 28(10):1047-1052. PubMed ID: 34278620
[TBL] [Abstract] [Full Text] [Related]
17. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile.
Rasmussen M; Lim K; Rambech E; Andersen MH; Svane IM; Andersen O; Jensen LH; Nilbert M; Therkildsen C
Gynecol Oncol; 2021 Sep; 162(3):686-693. PubMed ID: 34275654
[TBL] [Abstract] [Full Text] [Related]
18. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid cancer Patients With Central Neck Metastasis?
Han K; Noh HM; Jeong HM; Lim YC
Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093
[TBL] [Abstract] [Full Text] [Related]
19. Health-Related Quality of Life in Testicular cancer Survivors in Japan: A Multi-Institutional, Cross-Sectional Study Using the EORTC QLQ-TC26.
Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Yamada S; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Urology; 2021 Oct; 156():173-180. PubMed ID: 33785401
[TBL] [Abstract] [Full Text] [Related]
20. Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic cancer That Progressed After Gemcitabine (SEQUOIA).
Hecht JR; Lonardi S; Bendell J; Sim HW; Macarulla T; Lopez CD; Van Cutsem E; Muñoz Martin AJ; Park JO; Greil R; Wang H; Hozak RR; Gueorguieva I; Lin Y; Rao S; Ryoo BY
J Clin Oncol; 2021 Apr; 39(10):1108-1118. PubMed ID: 33555926
[TBL] [Abstract] [Full Text] [Related]
[Next]
